Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease
The potential value of young plasma-derived EXOs in AD treatment is revealed for the first time and, through RVG engineering strategies and the elucidation of the RPTOR-autophagy mechanism, provides new insights for targeted therapy of neurodegenerative diseases.